Research Excellence Program News Today

While it can take years for the pharmaceutical industry to create medicines capable of treating or curing human disease, a new study suggests that using generative artificial intelligence could vastly accelerate the drug-development process.

The effort of several years is required in the pharmaceutical industry to make medicines that have the potential to treat or cure human disease.

While it can take years for the pharmaceutical industry to create medicines capable of treating or curing human disease, a new study suggests that using generative artificial intelligence could vastly accelerate the drug-development process.

Perspective: Associate Dean for Research & Scholarship Researchers at the UConn School of Social Work continue to leverage partnerships with state

A US animal scientist, based at the University of Connecticut, will examine how over-feeding of the mother during gestation causes epigenetic changes in offspring liver that ultimately affect growth, metabolism, and inflammation.

This research will help scientists better manage this critical natural resource on a molecular level

Animal scientist Kristen Govoni wins $25,000 from the OVPR Research Excellence Program (REP) to explore how maternal over-nutrition affects offspring

Gerald “Gerry” Berkowitz’s study on the molecular and genetic mechanisms of trichomes in cannabis is an important first step to unlocking the promise

The UConn Office of the Vice President for Research has funded 40 new projects in the 2021 funding cycle for the Research Excellence Program. The

Researchers at UConn and Oregon State University are working to understand phonetic constancy in humans with help from automated speech recognition...